Polar Asset Management Partners’s Immunovant, Inc. Warrants expiring 12/18/2024 IMVTW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-168,429
Closed -$392K 628
2020
Q1
$392K Sell
168,429
-246,523
-59% -$473K 0.01% 334
2019
Q4
$809K Buy
+414,952
New +$840K 0.02% 319

Polar Asset Management Partners's IMVTW Position: Q2 2020 in Review

Polar Asset Management Partners sold out of Immunovant, Inc. Warrants expiring 12/18/2024 (IMVTW) in Q2 2020, closing a stake of 168,429 shares — an estimated $392K sold.

Polar Asset Management Partners first reported a position in IMVTW in Q4 2019 and held it in 2 quarters. The position peaked at $809K in Q4 2019. 0 funds tracked by Wall St. Rank hold IMVTW as of Q2 2020.

  • Polar Asset Management Partners reported no remaining Immunovant, Inc. Warrants expiring 12/18/2024 position as of Q2 2020 after selling out during the quarter.
  • Polar Asset Management Partners sold 168,429 Immunovant, Inc. Warrants expiring 12/18/2024 shares in Q2 2020, an estimated $392K.
  • Polar Asset Management Partners first reported a position in Immunovant, Inc. Warrants expiring 12/18/2024 in Q4 2019 and held it in 2 quarters.
  • Polar Asset Management Partners's Immunovant, Inc. Warrants expiring 12/18/2024 position peaked at $809K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Immunovant, Inc. Warrants expiring 12/18/2024 as of Q2 2020.

Based on Polar Asset Management Partners's 13F filing for Q2 2020, filed 14 Aug 2020.